BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 61.02% | 101.88% | 119.16% | 147.06% | 84.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.02% | 101.88% | 119.16% | 147.06% | 84.94% |
| Cost of Revenue | 41.67% | 57.21% | 77.92% | 70.75% | 25.25% |
| Gross Profit | 79.81% | 157.56% | 180.47% | 279.17% | 244.29% |
| SG&A Expenses | 16.44% | 77.61% | 19.60% | 24.93% | 43.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.82% | 64.72% | 38.72% | 44.06% | 41.92% |
| Operating Income | 33.82% | -4.73% | 38.23% | 43.83% | -0.47% |
| Income Before Tax | 59.25% | -55.70% | 75.89% | -775.13% | -157.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.14% | -55.70% | 75.89% | -775.13% | -157.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.14% | -55.70% | 75.89% | -775.13% | -157.84% |
| EBIT | 33.82% | -4.73% | 38.23% | 43.83% | -0.47% |
| EBITDA | 35.78% | 2.18% | 46.77% | 47.71% | 0.58% |
| EPS Basic | 66.91% | -20.51% | 80.23% | -747.43% | -133.65% |
| Normalized Basic EPS | 66.99% | -20.52% | 80.18% | -747.59% | -133.67% |
| EPS Diluted | 66.91% | -20.51% | 80.23% | -747.43% | -133.65% |
| Normalized Diluted EPS | 66.99% | -20.52% | 80.18% | -747.59% | -133.67% |
| Average Basic Shares Outstanding | 23.45% | 29.22% | 21.84% | 3.30% | 10.36% |
| Average Diluted Shares Outstanding | 23.45% | 29.22% | 21.84% | 3.30% | 10.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |